Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?

• by Margarete Teresa Walach, Ralph Burger, Felix Brumm, Katja Nitschke, Frederik Wessels, Philipp Nuhn, Thomas Stephan Worst, Jost von Hardenberg, Britta Grüne, Jonas Jarczyk

• January 29, 2025

International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

• by

• December 2, 2025

• 3 min

C5orf46: a promising prognosis risk indicator with implication in the remodeling of KIRC and pan-cancer tumor microenvironments

• by Lei Miao, Fei Wang, Xuzhi Wang, Huijun Yang, Jiayao Li, Siying Liu, Ningning Shen, Zhiqing Yang, Lifang Gao, Wenxia Ma, Chen Wang

• May 4, 2026

Checkmate 214 Presented by Toni Choueiri, MD.

Dr. Toni Choueiri shares groundbreaking 9-year results from the CHECKMATE-214 trial.

• June 11, 2025

• 1 min